SMARCA4 and neoplasm: In a series of 15 patients with CSS  and SMARCA4 PV, Li et al. reported two individuals with nonsense variants, associated with a milder phenotype; in the two male patients no tumor was reported by ages 9 and 15 years respectively [39].